Acasă › Cancer pulmonar cu celule non-pătrate › Kansas › Overland Park
Studii clinice pentru Cancer pulmonar cu celule non-pătrate în Overland Park, KS
16 studii pentru Cancer pulmonar cu celule non-pătrate caută participanți în și în jurul orașului Overland Park (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
În curs de recrutareFaza 1/2
- Kansas City Cancer Center /ID# 273679, Overland Park
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
În curs de recrutareFaza 3
- Research Site, Leawood · La 3 mi distanță
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
În curs de recrutareFaza 2
- University of Kansas Cancer Center, Fairway · La 3 mi distanță
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
În curs de recrutareFaza 3
- Saint Luke's South Hospital, Overland Park
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
În curs de recrutareFaza 2/3
- MidAmerica Cancer Care - Research, Merriam · La 3 mi distanță
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
În curs de recrutareFaza 3
- University of Kansas Cancer Center-Overland Park, Overland Park
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
În curs de recrutareFaza 1
- The University of Kansas Cancer Center - Indian Creek Campus, Overland Park
- The University of Kansas Cancer Center, Investigational Drug Services, Fairway · La 3 mi distanță
- The University of Kansas Clinical Research Center, Fairway · La 3 mi distanță
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · La 3 mi distanță
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · La 3 mi distanță
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2/3
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · La 3 mi distanță
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · La 3 mi distanță
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
În curs de recrutareFaza 1/2
- The University of Kansas Cancer Center, Fairway · La 3 mi distanță
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
În curs de recrutareStudiu observațional
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC
În curs de recrutareFaza 1/2
- The University of Kansas Cancer Center (KUCC), Fairway · La 3 mi distanță
A Study of IBI363 in Subjects with Advanced Solid Malignancies
În curs de recrutareFaza 2
- University of Kansas Medical Center (KUMC), Fairway · La 3 mi distanță
Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC
În curs de recrutareStudiu observațional
- The University of Kansas Cancer Center (KUCC), Fairway · La 3 mi distanță
Studii pentru Cancer pulmonar cu celule non-pătrate în alte orașe
- Houston, TX145 studii
- New York City, NY121 studii
- Arlington, VA104 studii
- Nashville, TN97 studii
- Boston, MA90 studii
- Los Angeles, CA87 studii
- St. Louis, MO73 studii
- Chicago, IL61 studii
- Baltimore, MD60 studii
- San Antonio, TX59 studii
- Columbus, OH57 studii
- Washington, DC55 studii
Alte studii în Overland Park
- Leucemie mieloasă acută11 studii
- Cancer pulmonar11 studii
- Cancer de sân10 studii
- Fibrilație atrială8 studii
- Cancer colorectal8 studii
- Obezitate7 studii
- Cancer pancreatic7 studii
- Cancer de prostată7 studii
- Melanom6 studii
- Supraponderalitate6 studii
- Cancer ovarian6 studii
- Cancer (toate tipurile)5 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.